News + Filings Transactions Holdings
All
13F
13D/G
Other
|
|
CRYSTAL ROGER
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 03/03/2023 |
4
| CRYSTAL ROGER (CEO) has filed a Form 4 on OPIANT PHARMACEUTICALS, INC.|
Txns:
| Disposed/sold 37,438 shares
@ $20, valued at
$748.8k
Disposed/sold 37,901 shares
@ $20, valued at
$758k
Disposed/sold 5,100 shares
@ $20, valued at
$102k
Granted 6,667 shares
@ $0
Disposed/sold 6,667 shares
@ $20, valued at
$133.3k
Disposed/sold 25,000 options
@ $6, valued at
$150k
Disposed/sold 150,000 options
@ $5, valued at
$750k
Disposed/sold 375,000 options
@ $7.25, valued at
$2.7M
Disposed/sold 13,200 options to buy
@ $14.62, valued at
$193k
Disposed/sold 27,250 options to buy
@ $13.6, valued at
$370.6k
Disposed/sold 31,250 options to buy
@ $12.15, valued at
$379.7k
|
|
| 01/31/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/09/2023 |
4
| CRYSTAL ROGER (CEO) has filed a Form 4 on OPIANT PHARMACEUTICALS, INC.|
Txns:
| Sold 1,183 shares
@ $20.2, valued at
$23.9k
|
|
| 01/05/2023 |
4
| CRYSTAL ROGER (CEO) has filed a Form 4 on OPIANT PHARMACEUTICALS, INC.|
Txns:
| Sold 5,029 shares
@ $20.2, valued at
$101.6k
|
|
| 08/15/2022 |
4
| CRYSTAL ROGER (Director) has filed a Form 4 on Mind Medicine (MindMed) Inc.|
Txns:
| Granted 89,286 shares
@ $0
Granted 120,968 options to buy
@ $0
Granted 503,773 options to buy
@ $0 |
|
| 08/15/2022 |
3
| CRYSTAL ROGER (Director) has filed a Form 3 on Mind Medicine (MindMed) Inc. |
| 07/15/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/29/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/17/2022 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 01/27/2022 |
4
| CRYSTAL ROGER (CEO) has filed a Form 4 on OPIANT PHARMACEUTICALS, INC.|
Txns:
| Sold 1,995 shares
@ $26.15, valued at
$52.2k
|
|
| 01/12/2022 |
4
| CRYSTAL ROGER (CEO) has filed a Form 4 on OPIANT PHARMACEUTICALS, INC.|
Txns:
| Sold 1,058 shares
@ $30.49, valued at
$32.3k
|
|
| 01/05/2022 |
4
| CRYSTAL ROGER (CEO) has filed a Form 4 on OPIANT PHARMACEUTICALS, INC.|
Txns:
| Granted 40,000 shares
@ $0 |
|
| 09/16/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/27/2021 |
4
| CRYSTAL ROGER (CEO) has filed a Form 4 on OPIANT PHARMACEUTICALS, INC.|
Txns:
| Granted 3,766 shares
@ $0
Granted 15,650 shares
@ $0
Granted 31,250 options to buy
@ $12.15, valued at
$379.7k
|
|
| 01/09/2020 |
4
| CRYSTAL ROGER (CEO) has filed a Form 4 on OPIANT PHARMACEUTICALS, INC.|
Txns:
| Granted 13,650 shares
@ $0
Granted 27,250 options to buy
@ $13.6, valued at
$370.6k
|
|
| 04/08/2019 |
4
| CRYSTAL ROGER (CEO) has filed a Form 4 on OPIANT PHARMACEUTICALS, INC.|
Txns:
| Sold 16,001 shares
@ $11.98, valued at
$191.7k
Sold 12,772 shares
@ $12.1, valued at
$154.5k
Exercised 21,472 options
@ $7.25, valued at
$155.7k
|
|
| 04/04/2019 |
4
| CRYSTAL ROGER (CEO) has filed a Form 4 on OPIANT PHARMACEUTICALS, INC.|
Txns:
| Sold 600 shares
@ $12.48, valued at
$7.5k
Sold 3,791 shares
@ $12.24, valued at
$46.4k
Sold 16,836 shares
@ $11.93, valued at
$200.9k
Exercised 822 options
@ $7.25, valued at
$6k
Exercised 5,149 options
@ $7.25, valued at
$37.3k
Exercised 22,557 options
@ $7.25, valued at
$163.5k
|
|
| 01/17/2019 |
4
| CRYSTAL ROGER (CEO) has filed a Form 4 on OPIANT PHARMACEUTICALS, INC.|
Txns:
| Granted 13,200 options to buy
@ $14.62, valued at
$193k
|
|
| 01/08/2019 |
4
| CRYSTAL ROGER (CEO) has filed a Form 4 on OPIANT PHARMACEUTICALS, INC.|
Txns:
| Sold 11,834 shares
@ $13.54, valued at
$160.2k
Exercised 25,000 shares
@ $6, valued at
$150k
Sold 26,759 shares
@ $13.28, valued at
$355.4k
Sold 11,407 shares
@ $13.27, valued at
$151.4k
Exercised 16,359 options
@ $7.25, valued at
$118.6k
Exercised 8,641 options
@ $7.25, valued at
$62.6k
Exercised 25,000 options
@ $6, valued at
$150k
|
|
| 10/10/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/04/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/28/2018 |
SC 13D
| Form SC 13D - General statement of acquisition of beneficial ownership: |
| 01/19/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
|
|